Sweater的动态

What’s the key to finding hidden value in today's venture landscape? In the latest episode of The Full Ratchet, I sat down with Gregory Ho, President, COO, and Head of Social Impact at Spring Mountain Capital, to discuss the art of "special situations" investing. Gregory reveals how Spring Mountain identifies undervalued opportunities across tech and healthcare sectors, driven by deep sector knowledge and a keen eye for unrecognized potential. We explore how AI is reshaping industries, with practical examples from healthcare to food waste management, and how Spring Mountain leverages its strategic approach to unlock value where others might not see it. Gregory also shares insights on their social impact strategy, emphasizing democratizing access to life sciences and tech opportunities for underrepresented communities. Tune in to Episode 450 of The Full Ratchet to learn from Gregory Ho's unique perspectives on creating value through thoughtful investment strategies and meaningful impact. Don’t miss this enlightening discussion! Link to the full episode is in the comment section below.

Did you know your LP experience can help refine your process as a direct investor? Our latest episode of Swimming with Allocators is now live! This week, we're thrilled to feature Jason Calacanis, an influential figure in the tech and VC communities. In our discussion, Jason delves into the evolution of his investment criteria over time, informed by his extensive experience as an LP. Plus, don’t miss Jason’s predictions on what’s next for the VC industry, where AI and streamlined business constructions are setting the stage for a new era. Tune in to gain invaluable insights that could redefine your approach to venture capital. ?? #PodcastRelease #VCInsights #InvestmentTips

VCs Shift Focus: From Investment Teams to Impact Teams. ?? ?? ?? Venture Unlocked with Samir Kaji from Allocate is one of my go-to podcasts. In the most recent episode with Benjamin Sun, cofounder at Primary Venture Partners, they went deep into investment data to help understand the Primary investment thesis and how they drive ROI. "Almost two-thirds of the organization are what we call our impact team. These are all operators dedicated with helping our companies after we invest." Ben Sun As an executive at Nobody Studios and a member of VC Platform, this quote from Ben jumped out. They focus on helping their portfolio graduate from Seed to Series A, directly impacting the portfolio with rigor and expertise. #future #venturecapital #innovation

In the latest release of the STEM Stories podcast, Georgina sits down with Lee Booty, Venture Principal Scientist at WEHI Ventures in Melbourne, Australia. Lee is a Venture Principal Scientist at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, where he helps manage a $66 million strategic investment fund through WEHI Ventures. Over the next decade, he will invest in early discovery and preclinical research, bridging the gap between scientific innovation and commercial ventures. This episode is a must-listen for anyone interested in the intersection of science, innovation, and industry collaboration. An exciting place to be! https://lnkd.in/eiuVRZGW https://lnkd.in/ebwAGr9T

How can venture capital help shape the future of healthcare? Listen to Nina Rawal, Partner at Trill Impact and Position Green's Executive Chairman Joachim Nahem discuss the transformative potential of impact investing in addressing health inequalities and improve access to healthcare globally. Tune in!

In the latest release of the STEM Stories podcast, Georgina sits down with Lee Booty, Venture Principal Scientist at WEHI Ventures in Melbourne, Australia. Lee is a Venture Principal Scientist at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, where he helps manage a $66 million strategic investment fund through WEHI Ventures. Over the next decade, he will invest in early discovery and preclinical research, bridging the gap between scientific innovation and commercial ventures. This episode is a must-listen for anyone interested in the intersection of science, innovation, and industry collaboration. An exciting place to be! https://lnkd.in/eKv2v_ZG https://lnkd.in/evcpg5ry

??? What’s the secret to transforming scientific concepts into marketable products? We tackle that and more in our latest Building Biotechs podcast episode featuring Stacie Frye, co-founder and CCO of Stimulus Bio! Here are some key takeaways: 1. The importance of bridging the gap between scientific innovation and commercialization in biotech startups 2. Leveraging mentors and consultants with past startup experience to guide new biotech ventures through critical growth stages 3. The emerging trends in biotech funding and the creative approaches to secure non-dilutive funding 4. Insights into Houston's growing biotech ecosystem and its potential as an emerging hub 5. The critical role of marketing, storytelling, and team building in startup success This was such a fun conversation, so grab the link from the comments and learn from Stacie’s experience! #BiotechStartup #ScienceInnovation #Biotechnology #MedicalDevice #BuildingBiotechs

In this episode of How to Sell Your Vision, I had the pleasure of hosting Angelos Chronis, the founder and CEO of infrared.city, a fascinating company providing environmental simulations that illustrate how newly designed structures can impact the environment. Its applications are broad and critically important, ranging from city planning to bridges and more. One of the key insights Angelos shared was the importance of knowing exactly why you're asking for a specific funding round and how you plan to allocate those funds. It’s a topic I’ve been hearing more and more about lately. It seems straightforward, right? If you’re asking for money, you should know how you’re going to use it. I agree with Angelos’ sentiments: especially in early-stage startups, where assumptions often outweigh historical data, investors want to see that your use of funds is grounded in solid research and a clear understanding of costs. Showing, in detail, what you’ll do with the money, is a great gateway for investors to have a feel of how you will treat their money. If your reasoning isn’t solid, realistic, and well-grounded, investment simply won’t follow. For the full episode - https://lnkd.in/e_gitMPH

After a period of high volatility in the biotech market, public investors are showing an increased appetite for funding younger companies. Meanwhile in the private market, venture capital mega-rounds continue to reflect the availability of capital. No?l Brown, Head of U.S. Biotechnology Investment Banking, RBC Capital Markets, explores investor potential in public and private biotech markets with Srini Akkaraju, Founder and Managing Partner, Samsara BioCapital, and Craig Gordon, Founder, CEO and CIO, GordonMD? Global Investments LP, on the latest episode of our Pathfinders in Biopharma podcast. Listen now: https://spr.ly/6048Q6634

?? S8E7 ?? Our guest for this week is Creator Ventures Co-Founder & Managing Partner, Sasha Kaletsky ?? Creator Ventures is a consumer-internet, early-stage venture capital firm focusing on “companies advancing how humans interact.” In this episode, Sasha joins James Pringle to discuss: ? The advantage of creators in Venture Capital ?? Challenges and Insights in Consumer Internet Investing? ??? AI Applications and Defensibility in Investments Listen Now ????? #founder #ceo #businesstips #podcast #ConsumerInternet #AI #CreatorEconomy